Management Thesis Ppt On Ranbaxy Pharma

PRESENTATION ON INTERIM EVALUATION OF MANAGEMENT THESIS SUBMITTED TO:- MR. AJAY PATOLE PRESENTED BY:- ASHISH RAHATE (8NBNG169)

A Thesis on “TO STUDY PROMOTIONAL STRATEGY ADOPTED BY RANBAXY LABORATORIES LTD RELATED TO RANITIDINE-150mg (Antiulcerant) IN NAGPUR CITY”

INTRODUCTION OBJECTIVES:-



To study the overview of Indian Pharmaceutical

Market. To study the culture of Ranbaxy Lab. To find out the promotional strategies used by Ranbaxy with respect to ‘Histac’ tab. To find out various promotional strategies used by Ranbaxy to acquire market share in Nagpur city. To study the competitors of ‘Histac’ in pharma market. To study the perceptions of Doctors on sales of ‘Histac’ 

LIMITATIONS:The scope of study is limited to Nagpur City only. There may be discrepancies in the actual data and

the recorded data due to misinterpretations. Topic is vast but availability of information and timeline is short. Unable to meet the decision maker of the organization.   

SALES PROMOTION Definition: Sales promotion can be defined as an activity taken up to boost the sales of a product. 



Purpose of Sales promotion:Encourage the customers to try a new product. Attract new customers Encourage the customers to use the product or service and make them brand loyal. 

  

INDUSTRY PROFILE The Indian Pharmaceutical Industry today is in the

front rank of India’s science-based industries . The Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units Several Indian pharmaceutical companies have acquired companies in the US and Europe and many others .

COMPANY PROFILE Ranbaxy Laboratories Limited, India's largest

pharmaceutical company Ranked 8th amongst the global generic pharmaceutical companies The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, R&D has a pool of over 1,200 scientists engaged in research. 

SWOT ANALYSIS 

STRENGTHS

Low cost of production. Efficient technologies

for large number of Generics.

Large pool of skilled

technical manpower.

WEAKNESS



Low technology level of

Capital Goods of this section. Very low key R&D. Very low level of

Biotechnology for New Drug Discovery Systems

SWOT ANALYSIS cont… THREATS

OPPORTUNITY





 Growing attention for health.

 High Cost of discovering new

products and fewer discoveries.

 New therapy approaches.  Globalization

 Stricter registration

procedures.



 Growing incomes.  New diagnoses and new social

diseases.

 High entry cost in newer

markets.

 High cost of sales and

marketing.







MISSION & VISION STATEMENT OF RANBAXY LAB. MISSION:-





“To become a research based international pharmaceutical company”.





VISION:-



  Achieving customer satisfaction is fundamental to our business. 

 Provide product and service of the highest quality. 

 Manage our operation with high concern for strategy and environment. 

 Be a responsible corporate citizen.  

RANITIDINE-150mg Ranitidine-150 mg is commonly used in treatment of

Peptic Ulcer Disease (PUD) and Gastro Esophageal Reflux Disease (GERD).

 HISTAC:

‘HISTAC’ is a product name of Ranbaxy Brand which is made up from ‘Ranitidine-150mg’ molecule



COMPETITORS OF ‘HISTAC’ tab. PRODUCT NAME

COMPANY

ZINETAC

GSK

ULTAC

CIPLA

ULFAST

SUN PHARMA

RANATAC

J.B.CHEMECALS

ZORAN

DR. REDDY

THANK YOU…..  